{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:22Z","timestamp":1791357442465,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.sleep.2019.11.1250","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:50:01Z","timestamp":1575460201000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy"],"prefix":"10.1016","volume":"67","author":[{"given":"Helene A.","family":"Emsellem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thorpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-0472","authenticated-orcid":false,"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen F.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Menno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib1","first-page":"233","article-title":"The medical and economic burden of narcolepsy: implications for managed care","volume":"10","author":"Thorpy","year":"2017","journal-title":"Am Health Drug Benefit"},{"issue":"suppl 1","key":"10.1016\/j.sleep.2019.11.1250_bib2","doi-asserted-by":"crossref","first-page":"A232","DOI":"10.1093\/sleep\/zsy061.624","article-title":"US prevalence of narcolepsy and other sleep disorders from 2018-2016: a retrospective, epidemiological study utilizing nationwide claims [abstract 0625]","volume":"41","author":"Hess","year":"2018","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2019.11.1250_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2019.11.1250_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","article-title":"Cataplexy\u2014clinical aspects, pathophysiology and management strategy","volume":"10","author":"Dauvilliers","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.sleep.2019.11.1250_bib5","series-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.sleep.2014.02.001","article-title":"The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings","volume":"15","author":"Black","year":"2014","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2019.11.1250_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.5664\/jcsm.5594","article-title":"The humanistic and economic burden of narcolepsy","volume":"12","author":"Flores","year":"2016","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2019.11.1250_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.2008.161588","article-title":"Psychological health in central hypersomnias: the French Harmony study","volume":"80","author":"Dauvilliers","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.sleep.2019.11.1250_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.sleep.2004.07.001","article-title":"Functional status in patients with narcolepsy","volume":"5","author":"Teixeira","year":"2004","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2019.11.1250_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2869.2001.00234.x","article-title":"Health-related quality of life in narcolepsy","volume":"10","author":"Daniels","year":"2001","journal-title":"J\u00a0Sleep Res"},{"issue":"7\u20138","key":"10.1016\/j.sleep.2019.11.1250_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.sleep.2006.10.010","article-title":"Health-related quality of life in patients with narcolepsy","volume":"8","author":"Dodel","year":"2007","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2019.11.1250_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/sleep\/27.6.1123","article-title":"The socioeconomic impact of narcolepsy","volume":"27","author":"Dodel","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2019.11.1250_bib14","series-title":"Narcolepsy public meeting on patient-focused drug development","author":"Food and Drug Administration","year":"2013"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40263-016-0337-4","article-title":"Treatment options for narcolepsy","volume":"30","author":"Barateau","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2019.11.1250_bib16","series-title":"Provigil [package insert]","year":"2018"},{"key":"10.1016\/j.sleep.2019.11.1250_bib17","series-title":"Nuvigil [package insert]","year":"2018"},{"issue":"2","key":"10.1016\/j.sleep.2019.11.1250_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.49.2.444","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy","volume":"49","author":"Broughton","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.sleep.2019.11.1250_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1389-9457(99)00014-3","article-title":"A\u00a0randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy","volume":"1","author":"Moldofsky","year":"2000","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2019.11.1250_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0987-7053(96)81535-8","article-title":"Use of modafinil in the treatment of narcolepsy: a long term follow-up study","volume":"26","author":"Besset","year":"1996","journal-title":"Neurophysiol Clin"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib21","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US modafinil in narcolepsy multicenter study group","volume":"54","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.sleep.2019.11.1250_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.sleep.2019.11.1250_bib23","first-page":"RA177","article-title":"Modafinil for narcolepsy: systematic review and meta-analysis","volume":"16","author":"Golicki","year":"2010","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5664\/jcsm.27935","article-title":"The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study","volume":"6","author":"Black","year":"2010","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.sleep.2019.11.1250_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/sleepj\/zsx050.650","article-title":"Assessing the benefits of sodium oxybate (SXB) on functioning, productivity, and health-related quality of life in people with narcolepsy: findings from the NEXUS narcolepsy registry [abstract 0651]","volume":"40","author":"Villa","year":"2017","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2019.11.1250_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40120-016-0053-5","article-title":"Evaluation of quality of life in patients with narcolepsy treated with sodium oxybate: use of the 36-item short-form health survey in a clinical trial","volume":"5","author":"Bogan","year":"2016","journal-title":"Neurol Ther"},{"issue":"9","key":"10.1016\/j.sleep.2019.11.1250_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/29.9.1189","article-title":"A\u00a0randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy","volume":"29","author":"Weaver","year":"2006","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2019.11.1250_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2019.11.1250_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2019.11.1250_bib30","series-title":"Sunosi\u2122 (solriamfetol) tablets prescribing information","year":"2019"},{"issue":"3","key":"10.1016\/j.sleep.2019.11.1250_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.25423","article-title":"A\u00a0randomized study of solriamfetol for excessive sleepiness in narcolepsy","volume":"85","author":"Thorpy","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2019.11.1250_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","article-title":"Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test","volume":"28","author":"Littner","year":"2005","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2019.11.1250_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2019.11.1250_bib34","first-page":"835","article-title":"An instrument to measure functional status outcomes for disorders of excessive sleepiness","volume":"20","author":"Weaver","year":"1997","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2019.11.1250_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/sleep\/32.7.915","article-title":"Development of the FOSQ-10: a short version of the functional outcomes of sleep questionnaire","volume":"32","author":"Chasens","year":"2009","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"PharmacoEconomics"},{"issue":"6","key":"10.1016\/j.sleep.2019.11.1250_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.sleep.2019.11.1250_bib38","series-title":"Measuring functioning and well-being: the medical outcomes study approach","first-page":"325","article-title":"Construct validity of MOS health measures","author":"Hays","year":"1992"},{"key":"10.1016\/j.sleep.2019.11.1250_bib39","series-title":"EQ-5D-5L user guide","author":"van Reenen","year":"2015"},{"issue":"12","key":"10.1016\/j.sleep.2019.11.1250_bib40","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jclinepi.2011.09.008","article-title":"US general population norms for telephone administration of the SF-36v2","volume":"65","author":"Maglinte","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.sleep.2019.11.1250_bib42","series-title":"Function and work productivity measures in a phase 3, randomized, placebo-controlled, double-blind, multicenter, 12-week study of the safety and efficacy of JZP-110 for the treatment of excessive sleepiness in patients with obstructive sleep apnea [poster]","author":"Bogan","year":"2017"},{"key":"10.1016\/j.sleep.2019.11.1250_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yebeh.2015.12.018","article-title":"Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: an analysis from the national health and wellness survey","volume":"55","author":"Gupta","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.sleep.2019.11.1250_bib44","series-title":"Using multiple anchor-based and distribution-based estimates to determine the minimal important difference (MID) for the functional outcomes of sleep questionnaire (FOSQ)-10 [poster 343]","author":"Weaver","year":"2018"},{"issue":"5","key":"10.1016\/j.sleep.2019.11.1250_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"issue":"11","key":"10.1016\/j.sleep.2019.11.1250_bib46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40273-015-0295-6","article-title":"Can the EQ-5D detect meaningful change? A systematic review","volume":"33","author":"Payakachat","year":"2015","journal-title":"PharmacoEconomics"},{"issue":"14","key":"10.1016\/j.sleep.2019.11.1250_bib47","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0000000000003787","article-title":"Measurement of narcolepsy symptoms: the Narcolepsy Severity Scale","volume":"88","author":"Dauvilliers","year":"2017","journal-title":"Neurology"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994571931634X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994571931634X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:20:50Z","timestamp":1761405650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138994571931634X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":47,"alternative-id":["S138994571931634X"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2019.11.1250","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2019.11.1250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}